secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2023-05-08T23:59:59+00:00
Accession:  0001558370-23-008560
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q1 revenue up 23% to $58.8M; raises FY2023 guidance to $271-275M
--------------------------------------------------------------------------------

- Q1 revenue $58.8M (+23% YoY); net loss narrowed to $1.9M ($0.09 diluted) from $15.6M loss ($0.78).
- Lymphedema revenue +22%, airway clearance +24%; gross margin 70.5%.
- Adjusted EBITDA turned positive to $0.5M from ($2.6M) loss in Q1 2022.
- FY2023 revenue guidance raised to $271-275M (prior $269-273M), growth ~10-11.5%.
- Closed public equity offering raising $34.6M net; appointed Elaine Birkemeyer as CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837023008560/0001558370-23-008560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837023008560/tcmd-20230508x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-008560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer